MECHANISM OF DELAYED INCREASES IN KYNURENINE PATHWAY METABOLISM IN DAMAGED BRAIN-REGIONS FOLLOWING TRANSIENT CEREBRAL-ISCHEMIA

被引:158
作者
SAITO, K
NOWAK, TS
MARKEY, SP
HEYES, MP
机构
[1] NIMH, CLIN SCI LAB,ANALYT BIOCHEM SECT,BLDG 10, ROOM 3D40, BETHESDA, MD 20892 USA
[2] NINCDS, STROKE BRANCH, BETHESDA, MD 20892 USA
关键词
INDOLEAMINE-2,3-DIOXYGENASE; KYNURENINASE; KYNURENINE; 3-HYDROXYLASE; 3-HYDROXYANTHRANILATE-3,4-DIOXYGENASE; KYNURENINE TRANSAMINASE; QUINOLINIC ACID; CEREBRAL ISCHEMIA; INFLAMMATION; MACROPHAGES; GERBIL; BRAIN;
D O I
10.1111/j.1471-4159.1993.tb05836.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Delayed increases in the levels of an endogenous N-methyl-D-aspartate receptor agonist, quinolinic acid (QUIN), have been demonstrated following transient ischemia in the gerbil and were postulated to be secondary to induction of indoleamine-2,3-dioxygenase (IDO) and other enzymes of the L-tryptophan-kynurenine pathway. In the present study, proportional increases in IDO activity and QUIN concentrations were found 4 days after 10 min of cerebral ischemia, with both responses in hippocampus > striatum > cerebral cortex > thalamus. These increases paralleled the severity of local brain injury and inflammation. IDO activity and QUIN concentrations were unchanged in the cerebellum of postischemic gerbils, which is consistent with the preservation of blood flow and resultant absence of pathology in this region. Blood QUIN and L-kynurenine concentrations were not affected by ischemia. Brain tissue QUIN levels at 4 days postischemia exceeded blood concentrations, minimizing a role for breakdown of the blood-brain barrier. Marked increases in the activity of kynureninase, kynurenine 3-hydroxylase, and 3-hydroxyanthranilate-3,4-dioxygenase were also detected in hippocampus but not in cerebellum on day 4 of recirculation. In vivo synthesis of [C-13(6)]QUIN was demonstrated, using mass spectrometry, in hippocampus but not in cerebellum of 4-day postischemic animals 1 h after intracisternal administration Of L-[C-13(6)]tryptophan. However, accumulation of QUIN was demonstrated in both cerebellum and hippocampus of control gerbils following an intracisternal injection of 3-hydroxyanthranilic acid, which verifies the availability of precursor to both regions when administered intracisternally. Notably, although IDO activity and QUIN concentrations were unchanged in the cerebellum of ischemic gerbils, both IDO activity and QUIN content were increased in cerebellum to approximately the same degree as in hippocampus, striatum, cerebral cortex, and thalamus 24 h after immune stimulation by systemic pokeweed mitogen administration, demonstrating that the cerebellum can increase IDO activity and QUIN content in response to immune activation. No changes in kynurenic acid concentrations in either hippocampus, cerebellum, or cerebrospinal fluid were observed in the postischemic gerbils compared with controls, in accordance with the unaffected activity of kynurenine aminotransferase activity. Collectively, these results support roles for IDO, kynureninase, kynurenine 3-hydroxylase, and 3-hydroxyanthranilate-3,4-dioxygenase in accelerating the conversion Of L-tryptophan and other substrates to QUIN in damaged brain regions following transient cerebral ischemia. Immunocytochemical results demonstrated the presence of macrophage infiltrates in hippocampus and other brain regions that parallel the extent of these biochemical changes. We hypothesize that increased kynurenine pathway metabolism after ischemia reflects the presence of macrophages and other reactive cell populations at sites of brain injury.
引用
收藏
页码:180 / 192
页数:13
相关论文
共 65 条
  • [11] KYNURENIC ACID BLOCKS NEUROTOXICITY AND SEIZURES INDUCED IN RATS BY THE RELATED BRAIN METABOLITE QUINOLINIC ACID
    FOSTER, AC
    VEZZANI, A
    FRENCH, ED
    SCHWARCZ, R
    [J]. NEUROSCIENCE LETTERS, 1984, 48 (03) : 273 - 278
  • [12] QUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE IN RAT-BRAIN
    FOSTER, AC
    ZINKAND, WC
    SCHWARCZ, R
    [J]. JOURNAL OF NEUROCHEMISTRY, 1985, 44 (02) : 446 - 454
  • [13] BLOOD-BRAIN-BARRIER TRANSPORT OF KYNURENINES - IMPLICATIONS FOR BRAIN SYNTHESIS AND METABOLISM
    FUKUI, S
    SCHWARCZ, R
    RAPOPORT, SI
    TAKADA, Y
    SMITH, QR
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 56 (06) : 2007 - 2017
  • [14] GAGNON J, 1989, SUPERANOVA
  • [15] IMMUNOCYTOCHEMICAL STUDY OF AN EARLY MICROGLIAL ACTIVATION IN ISCHEMIA
    GEHRMANN, J
    BONNEKOH, P
    MIYAZAWA, T
    HOSSMANN, KA
    KREUTZBERG, GW
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1992, 12 (02) : 257 - 269
  • [16] NEUROACTIVE KYNURENINES IN LYME BORRELIOSIS
    HALPERIN, JJ
    HEYES, MP
    [J]. NEUROLOGY, 1992, 42 (01) : 43 - 50
  • [17] QUANTIFICATION OF KYNURENIC ACID IN CEREBROSPINAL-FLUID - EFFECTS OF SYSTEMIC AND CENTRAL L-KYNURENINE ADMINISTRATION
    HEYES, MP
    QUEARRY, BJ
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 530 (01): : 108 - 115
  • [19] QUINOLINIC ACID IN CEREBROSPINAL-FLUID AND SERUM IN HIV-1 INFECTION - RELATIONSHIP TO CLINICAL AND NEUROLOGICAL STATUS
    HEYES, MP
    BREW, BJ
    MARTIN, A
    PRICE, RW
    SALAZAR, AM
    SIDTIS, JJ
    YERGEY, JA
    MOURADIAN, MM
    SADLER, AE
    KEILP, J
    RUBINOW, D
    MARKEY, SP
    [J]. ANNALS OF NEUROLOGY, 1991, 29 (02) : 202 - 209
  • [20] RELATIONSHIP OF NEUROLOGIC STATUS IN MACAQUES INFECTED WITH THE SIMIAN IMMUNODEFICIENCY VIRUS TO CEREBROSPINAL-FLUID QUINOLINIC ACID AND KYNURENIC ACID
    HEYES, MP
    JORDAN, EK
    LEE, K
    SAITO, K
    FRANK, JA
    SNOY, PJ
    MARKEY, SP
    GRAVELL, M
    [J]. BRAIN RESEARCH, 1992, 570 (1-2) : 237 - 250